Added to BSD Medical (BSM)
I’ve had a small position in BSD Medical (BSM) for several months, a few hundred shares that remained from a partial fill on a sell order. Today I ramped that position up substantially.
I like BSD Medical for three reasons. First, the stock has shown technical support in this area consistently over the past year. Second, the newsflow has been quite positive. Peer-reviewed articles in leading 
medical journals keep mentioning expanded uses for its thermal ablation devices, such as treating soft tissue sarcoma, pancreatic cancer and previously inoperable cervical cancer. The company believes its next generation thermal ablation device (pictured to the left) will have even broader uses. Third, given all of the positive studies (this one for example) I expect a positive resolution to the pending FDA application.
I think that BSM could easily rise 30% or so before FDA approval, and if it receives the nod from the FDA, could double or triple.
DISCLOSURE: I am long BSM. Not a recommendation to buy or sell any security. For informational and educational purposes only.
Like this? Subscribe to RSS | Comment | Bookmark on del.icio.us
